UTI (Urinary Tract Infection) is high on the list of the most common infections for women. It is caused by bacteria entering the urinary tract. In extreme cases, it can cause some damage to the kidney. While UTIs are curable, the treatment usually involves a lot of antibiotics and suppositories, many of which have undesirable side effects.
However, a unique antibiotic with the potential to treat UTIs faster than the previous medications is being developed by GSK. This new drug is called gepotidacin.
GSK’s Gepotidacin has emerged as a new and innovative system to slow down or prevent completely the replication of the bacteria that causes UTI.
The company mentioned that it would have its findings ready for publishing in a medical journal and would send its data to the FDA for approval in the upcoming year. According to the website clinicaltrials.gov, this is approximately one year earlier than the study’s estimated completion date.
If given the green light, gepotidacin will be the first major antibiotic created for treating urinary tract infections (UTIs) in more than twenty years.
Why is This New Antibiotic a Good Thing for UTIs
According to experts, the possibility that there may be a new treatment for urinary tract infections (UTIs) is great because the bacteria that cause UTIs are evolving. This is true both for cases of simple UTIs and for situations of more difficult UTIs. We need new drugs to combat that.
Because of the gradually rising resistance to one of the antibiotics (Bactrim), there are now few treatment options available for the most prevalent types of urinary tract infections (UTIs), also known as bladder infections.
According to a report released by the World Health Organization in 2021, not enough effective drugs are being developed to combat the growing threat of antibiotic resistance. Treatments administered early and proven helpful are essential because, if they are not, the condition can progress to more serious kidney and blood infections, which can be fatal.
According to GSK, research investigating the effectiveness of gepotidacin in treating gonorrhea is still underway. It has yet to reach the same stage as the trial examining its efficacy in treating UTIs. Gepotidacin is administered in the form of a pill. Additionally, GSK is investigating it as a potential treatment for gonorrhea, an infection that is spread sexually.
When Can You Take Antibiotics for UTIs?
Antibiotics, in general, can potentially induce adverse effects such as allergic reactions, an increased chance of developing infections resistant to antibiotics in the future, and significant disturbances in our microbiome. As a result, antibiotics do not pair well with situations with no bacterial infections and should only be used on the doctor’s prescription.
